Who actually owns the downside?
This frame evaluates whether an individual, company, or system is building durable leverage — or operating inside a dependency where rules, economics, or access can be changed unilaterally.
The clearest transaction I have led where this frame determined the outcome was the controlling stake acquisition of Long Beach Outpatient Surgery.
The GI physicians who owned the center had built something real — a functioning outpatient surgery facility with clean financials, a loyal surgical team, and years of operating history. But they were operating inside a dependency they could not see clearly from the inside. As a small, independent center, they had no negotiating power with insurance providers or Medicare. They were accepting reimbursement rates that a better-positioned facility would never accept. The same procedures, performed at the same quality level, were being paid at small-center rates because the center lacked the institutional affiliation required to negotiate otherwise.
The dependency was structural, not operational. The center ran well. The physicians were skilled. The problem was that the rules of their reimbursement relationship could be set unilaterally by payers — and the center had no leverage to change them.
The acquisition converted that dependency into leverage. Affiliating with Surgical Care Affiliates — a platform that was later acquired by UnitedHealth Group's Optum for $2.3 billion — gave the center access to negotiated rate structures it could never have achieved independently. GI reimbursement rates increased 20% per case post-rebrand. Not because the procedures changed. Because the institutional relationship changed.
The multi-specialty expansion that followed — cardiovascular, orthopedic, peripheral vascular, spine — compounded the leverage. Each new specialty brought higher-margin procedures and a more diversified revenue base. The center that had been a rate-constrained single-specialty dependency became a structurally advantaged multi-specialty platform. The value tripled over eight years.
The lesson is not specific to healthcare. Every business that depends on an external party to set the terms of its most important relationships is operating inside a dependency. The question is always the same: who owns the downside if those terms change?
The full case study shows how dependency was identified in diligence and converted into leverage through deal structure and post-acquisition execution.
Long Beach Surgical Center — dependency converted to leverage →
BuzzAngle Music — scarcity as leverage against a duopoly →
Sourcing Journal — founder leverage through category authority →
Leverage exists when outcomes improve disproportionately with scale, while downside remains bounded or optional.
Dependency exists when upside is shared but downside is asymmetric — especially when another party can alter terms, access, or visibility at will.
This frame applies whenever success depends on an external system, platform, intermediary, or gatekeeper — especially in periods of technological transition.
It is foundational in evaluating media, technology platforms, marketplaces, capital structures, and AI-mediated visibility.
Decision: Does the buyer control the conditions required to capture value after the acquisition?
In an acquisition, dependency is reliance on a person or counterparty who can change a critical condition the buyer cannot readily replace. Leverage is a usable alternative or control right that changes the negotiated or operating outcome. Scale can help, but scale alone does not create either an alternative or a right.
| Test | Evidence question | Consequence |
|---|---|---|
| Control | Who owns the relationship, access, pricing authority, data permission, or critical qualification? | Separate ownership of the company from control of the economic condition. |
| Replacement | What would replacing that person or counterparty cost, and how long would it take? | Model interruption, recurring replacement cost, and transition cash. |
| Transfer | Does the relevant right, relationship, or capability survive this deal? | Obtain evidence and required consents before treating it as acquired value. |
| Exercise | Can the buyer actually use its alternative without destroying value? | An expensive or unavailable fallback is weak negotiating leverage. |
Proceed only if critical dependencies can transfer, be replaced, or be protected on acceptable economics. Price recurring exposure and transition cash separately. Hold a critical gate for missing evidence; walk when the missing capability breaks the thesis.
Illustrative: a founder controls customer renewals while a manager handles routine delivery. Buying the shares does not by itself transfer customer trust. Test a successor-led renewal and fund the handover before assuming the earnings survive.
Dependence can be economically worthwhile. The test is the consequence and available response, not independence for its own sake. Insurance or contingent payment may offset loss but does not deliver the missing operating capability.
Founder dependency and transferability · Seller dependencies and TSA exit · Counterparty alternatives and leverage
Method and update: transaction application v3.1, September 30, 2026. Practitioner decision table derived from Mike Ye’s existing dependency vs leverage frame, published cases, and deal tools; synthesis and implementation by Ella. Inputs are transaction-specific evidence, alternatives, costs, rights, and next commitments. Use for material conditions that can change the recommendation. Illustrative examples are fictional. This qualitative test is not a calibrated score and cannot establish undisclosed facts. The existing essay and transaction examples remain the foundation.
Use the due diligence guide. Test who controls the customer relationship, access, operating decisions, and rights. Record what must transfer or be protected.
Map separation dependencies · Five decision frameworks · M&A Library